Cart
sales@molnova.com
MC3482
CAS No.
MC3482 ( MC 3482 )
Catalog No. M17074 CAS No.
MC3482 is a potent, specific SIRT5 inhibitor, increases the ammonia content in cells leading to autophagy and mitophagy, shows selective SIRT5 inhibition vs SIRT1-3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMC3482
-
NoteResearch use only, not for human use.
-
Brief DescriptionMC3482 is a potent, specific SIRT5 inhibitor, increases the ammonia content in cells leading to autophagy and mitophagy, shows selective SIRT5 inhibition vs SIRT1-3.
-
DescriptionMC3482 is a potent, specific SIRT5 inhibitor, increases the ammonia content in cells leading to autophagy and mitophagy, shows selective SIRT5 inhibition vs SIRT1-3.
-
SynonymsMC 3482
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorSirtuin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight618.69
-
Molecular FormulaC33H38N4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(S)-2-(((benzyloxy)carbonyl)amino)-5-(((S)-5-(((benzyloxy)carbonyl)amino)-6-oxo-6-(phenylamino)hexyl)amino)-5-oxopentanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Polletta L, et al. Autophagy. 2015;11(2):253-70.
molnova catalog
related products
-
Nicotinamide ribosid...
Nicotinamide riboside chloride also known as NR and SRT647 is a pyridine-nucleoside form of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+.
-
SirReal1
A novel potent, selective Sirt2 inhibitor with IC50 of 3.745 uM.
-
RK-9123016
RK-9123016 is a SIRT2 inhibitor. RK-9123016 increases the acetylation level of eukaryotic translation initiation factor 5A (eIF5A), a physiological substrate of SIRT2, and reduces cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression.
